<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00836420</url>
  </required_header>
  <id_info>
    <org_study_id>KF 00/002</org_study_id>
    <nct_id>NCT00836420</nct_id>
  </id_info>
  <brief_title>Cerebral Microdialysis in Patients With Fulminant Hepatic Failure</brief_title>
  <official_title>Cerebral Microdialysis in Patients With Fulminant Hepatic Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with fulminant hepatic failure (FHF) often develop cerebral edema, high intracranial
      pressure (ICP)that may result in fatal brain damage. The aim in this protocol is to determine
      if a rise in the brain concentration of glutamate, lactate and pyruvate are involved in
      development of surges of high ICP in patients with FHF. The study is observatory in nature
      and also record the influence of any intervention that may e instituted during the course of
      the critical illness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fulminant hepatic failure (FHF) is often complicated by cerebral edema, high intracranial
      pressure (ICP) and brain death. Accordingly the intracranial pressure is often monitored in
      such patients in order to be able to institute treatment before high ICP evolves. As
      routinely done in patients with severe head injury a microdialysis monitoring catheter is
      also placed under this procedure to measure metabolic changes that are responsible for surges
      of high ICP. The aim in this descriptive protocol is to determine if a rise in glutamate,
      lactate and pyruvate concentration in the brain cortex are involved in development of surges
      of high ICP in patients with FHF. The study is observatory in nature and also record the
      influence of any intervention during the course of the critical illness.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2000</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Brain lactate concentration and intracranial hypertension</measure>
    <time_frame>2013</time_frame>
    <description>to determine if brain oxidative metabolism correlates with brain edema and high intracranial pressure</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Fulminant Hepatic Failure</condition>
  <arm_group>
    <arm_group_label>liver</arm_group_label>
    <description>patients with acute liver failure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>the value of the clinical use of microdialysis monitoring of the brain</description>
    <arm_group_label>liver</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      microdialysate from the brain as part of rutine monitoring
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive patients with fulminant hepatic failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with fulminant hepatic failure

        Exclusion Criteria:

          -  Age below 18 years

          -  Pregnancy

          -  Not obtained informed consent

          -  Suspicion of cancer disease

          -  No pupil reaction to light
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fin Stolze Larsen</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet Dept Hepatology A-2121</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Tofteng F, Jorgensen L, Hansen BA, Ott P, Kondrup J, Larsen FS. Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology. 2002 Dec;36(6):1333-40.</citation>
    <PMID>12447856</PMID>
  </reference>
  <reference>
    <citation>Bjerring PN, Hauerberg J, Jørgensen L, Frederiksen HJ, Tofteng F, Hansen BA, Larsen FS. Brain hypoxanthine concentration correlates to lactate/pyruvate ratio but not intracranial pressure in patients with acute liver failure. J Hepatol. 2010 Dec;53(6):1054-8. doi: 10.1016/j.jhep.2010.05.032. Epub 2010 Aug 3.</citation>
    <PMID>20800925</PMID>
  </reference>
  <reference>
    <citation>Bjerring PN, Hauerberg J, Frederiksen HJ, Jorgensen L, Hansen BA, Tofteng F, Larsen FS. Cerebral glutamine concentration and lactate-pyruvate ratio in patients with acute liver failure. Neurocrit Care. 2008;9(1):3-7. doi: 10.1007/s12028-008-9060-4.</citation>
    <PMID>18250976</PMID>
  </reference>
  <reference>
    <citation>Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jørgensen L, Larsen FS. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2006 Jan;26(1):21-7.</citation>
    <PMID>15959460</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2009</study_first_submitted>
  <study_first_submitted_qc>February 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2009</study_first_posted>
  <last_update_submitted>October 26, 2015</last_update_submitted>
  <last_update_submitted_qc>October 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Dr. Fin Stolze Larsen</investigator_full_name>
    <investigator_title>consultant</investigator_title>
  </responsible_party>
  <keyword>ammonia</keyword>
  <keyword>acute liver failure</keyword>
  <keyword>brain edema</keyword>
  <keyword>oxidative metabolism</keyword>
  <keyword>intracranial pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Liver Failure, Acute</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

